This website is intended exclusively for healthcare professionals residing and/or working in Oman.
Evaluating the clinical effectiveness and safety of insulin glargine 300 U/ml in individuals with T2D uncontrolled on Basal insulin: A real-world evidence study form Saudi Arabia (EVOLUTION).
MAT-BH-2300744/V1/NOV2023
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.